Another study showed that inhibition of cytotoxic T lymphocyte antigen 4 (CTLA4) induced PD-L1 expression through activation the EGFR/ERK pathway in human NSCLC [104]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.